Edition:
United States

Dr.Reddy's Laboratories Ltd (REDY.BO)

REDY.BO on Bombay Stock Exchange

2,013.75INR
6:26am EDT
Change (% chg)

Rs119.40 (+6.30%)
Prev Close
Rs1,894.35
Open
Rs1,889.00
Day's High
Rs2,045.00
Day's Low
Rs1,889.00
Volume
128,271
Avg. Vol
61,890
52-wk High
Rs2,788.00
52-wk Low
Rs1,888.00

Latest Key Developments (Source: Significant Developments)

Dr.Reddy's Laboratories Gets EIR From US FDA For API Cuernavaca Plant In Mexico
Tuesday, 10 Apr 2018 02:06am EDT 

April 10 (Reuters) - Dr.Reddy's Laboratories Ltd ::SAYS GETS EIR FROM US FDA FOR API CUERNAVACA PLANT IN MEXICO.  Full Article

Dr.Reddy's Labs' U.S. Unit Announces ANDA Filing For Migraine Candidate
Monday, 2 Apr 2018 05:43am EDT 

April 2 (Reuters) - Dr.Reddy's Laboratories Ltd ::CO, U.S. UNIT PROMIUS PHARMA ANNOUNCE FILING OF AN NDA FOR MIGRAINE CANDIDATE.UPON APPROVAL, PRODUCT WILL BE COMMERCIALISED BY PROMIUS PHARMA.  Full Article

Dr.Reddy's Laboratories Appoints Erez Israeli As Chief Operating Officer
Thursday, 29 Mar 2018 01:03am EDT 

March 29 (Reuters) - Dr.Reddy's Laboratories Ltd ::CHIEF OPERATING OFFICER ABHIJIT MUKHERJEE TO RETIRE ON MARCH 31.APPOINTS EREZ ISRAELI AS CHIEF OPERATING OFFICER.  Full Article

Dr.Reddy's Labs Gets Form 483 With 4 Observations For API Hyderabad Plant Audit
Friday, 16 Mar 2018 05:36am EDT 

March 16 (Reuters) - Dr.Reddy's Laboratories Ltd ::SAYS AUDIT OF API HYDERABAD PLANT IN TELENGANA BY U.S. FDA COMPLETED ON MARCH 16.SAYS CO BEEN ISSUED ONE FORM 483 WITH 4 OBSERVATIONS.  Full Article

Dr.Reddy's Laboratories Launches Levocetirizine Dihydrochloride Tablets USP, 5 Mg In U.S.
Friday, 16 Mar 2018 01:58am EDT 

March 16 (Reuters) - Dr.Reddy's Laboratories Ltd ::ANNOUNCES LAUNCH OF LEVOCETIRIZINE DIHYDROCHLORIDE TABLETS USP, 5 MG IN U.S. MARKET.  Full Article

India's Dr.Reddy's Laboratories Gets 5 Observations From U.S FDA For API Unit At Hyderabad ‍​
Friday, 9 Mar 2018 04:53am EST 

March 9 (Reuters) - Dr.Reddy's Laboratories Ltd ::U.S FDA ISSUES FORM 483 WITH 5 OBSERVATIONS FOR API UNIT AT HYDERABAD ‍​.  Full Article

Dr.Reddy's Laboratories Says Amended Complaint w.r.t U.S. Class Action Lawsuit Filed
Monday, 19 Feb 2018 01:33am EST 

Feb 19 (Reuters) - Dr.Reddy's Laboratories Ltd ::W.R.T U.S. CLASS ACTION LAWSUIT, AMENDED COMPLAINT FILED BY PLAINTIFF WHERE CHAIRMAN, COO AND U.S. UNIT ADDED AS DEFENDANTS.  Full Article

Dr.Reddy's Lab Announces Launch Of Tetrabenazine Tablets In U.S. Market
Friday, 2 Feb 2018 12:59am EST 

Feb 2 (Reuters) - Dr.Reddy's Laboratories Ltd ::SAYS ANNOUNCEMENT OF LAUNCH OF TETRABENAZINE TABLETS IN U.S. MARKET.  Full Article

India's Dr.Reddy's Laboratories Dec-Qtr Consol Net PAT Falls 38.5 Pct
Thursday, 25 Jan 2018 01:31am EST 

Jan 25 (Reuters) - Dr.Reddy's Laboratories Ltd ::DEC QUARTER CONSOL NET PROFIT AFTER TAX 3.03 BILLION RUPEES VERSUS PROFIT OF 4.92 BILLION RUPEES LAST YEAR.DEC QUARTER CONSOL TOTAL REVENUE FROM OPERATIONS 38.34 BILLION RUPEES VERSUS 37.23 BILLION RUPEES LAST YEAR.CONSENSUS FORECAST FOR DEC QUARTER CONSOL PROFIT WAS 3.40 BILLION RUPEES.  Full Article

Dr.Reddy's Laboratories Updates on Re-inspection At Formulations Mfg Plant In Bachupally
Wednesday, 24 Jan 2018 08:21am EST 

Jan 24 (Reuters) - Dr.Reddy's Laboratories Ltd ::THERE HAS BEEN RE-INSPECTION BY GERMAN REGULATOR AT CO'S FORMULATIONS MANUFACTURING UNIT 2 PLANT IN BACHUPALLY, HYDERABAD‍​.BETAPHARM INFORMED THAT CURRENT STATUS OF EU GMP NON-COMPLIANCE IS TO BE WITHDRAWN FROM GOVERNMENT. OF UPPER BAVARIA.  Full Article

Indian shares close slightly higher; SBI, Dr.Reddy's gain on Q4 results

May 22 Indian shares ended slightly higher on Tuesday, driven by gains in Dr. Reddy's Laboratories Ltd and State Bank of India (SBI) following their quarterly results.